These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11385712)

  • 61. A proven de novo germline mutation in HNPCC.
    Kraus C; Kastl S; Günther K; Klessinger S; Hohenberger W; Ballhausen WG
    J Med Genet; 1999 Dec; 36(12):919-21. PubMed ID: 10594000
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden.
    Cederquist K; Emanuelsson M; Göransson I; Holinski-Feder E; Müller-Koch Y; Golovleva I; Grönberg H
    Int J Cancer; 2004 Apr; 109(3):370-6. PubMed ID: 14961575
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC).
    Loukola A; Eklin K; Laiho P; Salovaara R; Kristo P; Järvinen H; Mecklin JP; Launonen V; Aaltonen LA
    Cancer Res; 2001 Jun; 61(11):4545-9. PubMed ID: 11389088
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome?
    Ollikainen M; Abdel-Rahman WM; Moisio AL; Lindroos A; Kariola R; Järvelä I; Pöyhönen M; Butzow R; Peltomäki P
    J Clin Oncol; 2005 Jul; 23(21):4609-16. PubMed ID: 15837969
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1.
    Syngal S; Fox EA; Eng C; Kolodner RD; Garber JE
    J Med Genet; 2000 Sep; 37(9):641-5. PubMed ID: 10978352
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Spectrum of germ-line MLH1 and MSH2 mutations in Austrian patients with hereditary nonpolyposis colorectal cancer.
    Wolf B; Henglmueller S; Janschek E; Ilencikova D; Ludwig-Papst C; Bergmann M; Mannhalter C; Wrba F; Karner-Hanusch J
    Wien Klin Wochenschr; 2005 Apr; 117(7-8):269-77. PubMed ID: 15926618
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Optimization of experimental conditions for RNA-based sequencing of MLH1 and MSH2 genes.
    Jakubowska A; Górski B; Kurzawski G; Debniak T; Hadaczek P; Cybulski C; Kladny J; Oszurek O; Scott RJ; Lubinski J
    Hum Mutat; 2001; 17(1):52-60. PubMed ID: 11139242
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.
    Shin KH; Shin JH; Kim JH; Park JG
    Cancer Res; 2002 Jan; 62(1):38-42. PubMed ID: 11782355
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
    Aaltonen LA; Salovaara R; Kristo P; Canzian F; Hemminki A; Peltomäki P; Chadwick RB; Kääriäinen H; Eskelinen M; Järvinen H; Mecklin JP; de la Chapelle A
    N Engl J Med; 1998 May; 338(21):1481-7. PubMed ID: 9593786
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel MLH1 mutations and a novel MSH2 polymorphism identified by SSCP and DHPLC in Portuguese HNPCC families.
    Isidro G; Matos S; Gonçalves V; Cavaleiro C; Antunes O; Marinho C; Soares J; Boavida MG
    Hum Mutat; 2003 Nov; 22(5):419-20. PubMed ID: 14517962
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining.
    Mangold E; Pagenstecher C; Friedl W; Fischer HP; Merkelbach-Bruse S; Ohlendorf M; Friedrichs N; Aretz S; Buettner R; Propping P; Mathiak M
    J Pathol; 2005 Dec; 207(4):385-95. PubMed ID: 16216036
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mutations predisposing to hereditary nonpolyposis colorectal cancer.
    Peltomäki P; de la Chapelle A
    Adv Cancer Res; 1997; 71():93-119. PubMed ID: 9111864
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques.
    Nakagawa H; Hampel H; de la Chapelle A
    Hum Mutat; 2003 Sep; 22(3):258. PubMed ID: 12938096
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mutations in MLH1 are more frequent than in MSH2 in sporadic colorectal cancers with microsatellite instability.
    Herfarth KK; Kodner IJ; Whelan AJ; Ivanovich JL; Bracamontes JR; Wells SA; Goodfellow PJ
    Genes Chromosomes Cancer; 1997 Jan; 18(1):42-9. PubMed ID: 8993979
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments.
    Charbonnier F; Raux G; Wang Q; Drouot N; Cordier F; Limacher JM; Saurin JC; Puisieux A; Olschwang S; Frebourg T
    Cancer Res; 2000 Jun; 60(11):2760-3. PubMed ID: 10850409
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA.
    Taylor CF; Charlton RS; Burn J; Sheridan E; Taylor GR
    Hum Mutat; 2003 Dec; 22(6):428-33. PubMed ID: 14635101
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A modified multiplex PCR assay for detection of large deletions in MSH2 and MLH1.
    Wang Y; Friedl W; Sengteller M; Jungck M; Filges I; Propping P; Mangold E
    Hum Mutat; 2002 Mar; 19(3):279-86. PubMed ID: 11857745
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Microsatellite instability and immunohistochemical analysis of MLH1 and MSH2 in normal endometrium, endometrial hyperplasia and endometrial cancer from a hereditary nonpolyposis colorectal cancer patient.
    Ichikawa Y; Tsunoda H; Takano K; Oki A; Yoshikawa H
    Jpn J Clin Oncol; 2002 Mar; 32(3):110-2. PubMed ID: 11956307
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Histologic comparison of hereditary nonpolyposis colorectal cancer associated with MSH2 and MLH1 and colorectal cancer from the general population.
    Shashidharan M; Smyrk T; Lin KM; Ternent CA; Thorson AG; Blatchford GJ; Christensen MA; Lynch HT
    Dis Colon Rectum; 1999 Jun; 42(6):722-6. PubMed ID: 10378595
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nationwide study of clinical and molecular features of hereditary non-polyposis colorectal cancer (HNPCC) in Latvia.
    Irmejs A; Borosenko V; Melbarde-Gorkusa I; Gardovskis A; Bitina M; Kurzawski G; Suchy J; Gorski B; Gardovskis J
    Anticancer Res; 2007; 27(1B):653-8. PubMed ID: 17348456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.